NO943682D0 - Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse - Google Patents

Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse

Info

Publication number
NO943682D0
NO943682D0 NO943682A NO943682A NO943682D0 NO 943682 D0 NO943682 D0 NO 943682D0 NO 943682 A NO943682 A NO 943682A NO 943682 A NO943682 A NO 943682A NO 943682 D0 NO943682 D0 NO 943682D0
Authority
NO
Norway
Prior art keywords
imidazol
preparation
therapeutic use
piperidine derivatives
piperidine
Prior art date
Application number
NO943682A
Other languages
English (en)
Other versions
NO943682L (no
Inventor
Samir Jegham
Gerard Defosse
Thomas Andrew Purcell
Luc Even
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of NO943682D0 publication Critical patent/NO943682D0/no
Publication of NO943682L publication Critical patent/NO943682L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO943682A 1993-10-04 1994-10-03 Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse NO943682L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9311771A FR2710915B1 (fr) 1993-10-04 1993-10-04 Dérivés de pipéridine, leur préparation et leur utilisation en thérapeutique.

Publications (2)

Publication Number Publication Date
NO943682D0 true NO943682D0 (no) 1994-10-03
NO943682L NO943682L (no) 1995-04-05

Family

ID=9451496

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943682A NO943682L (no) 1993-10-04 1994-10-03 Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse

Country Status (18)

Country Link
US (1) US5589476A (no)
EP (1) EP0646583A1 (no)
JP (1) JPH07179466A (no)
KR (1) KR950011435A (no)
CN (1) CN1109471A (no)
AU (1) AU7432994A (no)
CA (1) CA2133491A1 (no)
CZ (1) CZ241994A3 (no)
FI (1) FI944600A (no)
FR (1) FR2710915B1 (no)
HU (1) HUT71120A (no)
IL (1) IL111148A0 (no)
NO (1) NO943682L (no)
NZ (1) NZ264596A (no)
PL (1) PL305288A1 (no)
RU (1) RU94036003A (no)
SK (1) SK119494A3 (no)
ZA (1) ZA947710B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5500423A (en) * 1994-09-09 1996-03-19 Hoechst-Roussel Pharmaceuticals Inc. 5,6-dihydro-4H-imidazo[4,5,1-ij]quinolines
FR2731708B1 (fr) * 1995-03-13 1997-04-30 Synthelabo Derives de piperidine, leur procede de preparation et leur application en therapeutique
ES2191106T3 (es) * 1995-09-18 2003-09-01 Glaxo Group Ltd Uso de ondansetron en la fabricacion de un medicamento para el tratamiento del temblor.
FR2747678B1 (fr) * 1996-04-22 1998-05-22 Synthelabo Composes derives d'imidazobenzoxazine, leurs procedes de preparation et leurs utilisations en therapeutique
FR2753196B1 (fr) * 1996-09-12 1998-10-23 Synthelabo Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
HU228179B1 (en) * 1998-08-21 2013-01-28 Novartis Ag Pharmaceutical, oral compositions containing 5-ht4 agonists or antagonists as active agent
IT1303123B1 (it) 1998-10-13 2000-10-30 Rotta Research Lab Derivati basici di benz(e)isoindol-1-oni e pirrolo(3,4-c)chinolin-1-oni ad attivita' 5ht3 antagonista, loro preparazione ed
GB9918425D0 (en) * 1999-08-04 1999-10-06 Novartis Ag Organic compounds
FR2812878B1 (fr) * 2000-08-08 2002-10-11 Sanofi Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2816619B1 (fr) * 2000-11-15 2003-01-31 Sanofi Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
CA2412368A1 (fr) * 2000-08-08 2002-02-14 Sanofi-Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2816941B1 (fr) * 2000-11-23 2003-01-31 Sanofi Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
FR2816942B1 (fr) * 2000-11-23 2003-05-09 Sanofi Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
US20040242635A1 (en) * 2001-03-30 2004-12-02 Painter Rachel J. Encapsulated dyes in cosmetic compositions
WO2003104233A1 (en) * 2002-06-07 2003-12-18 Altana Pharma Ag 4,5-dihydro-imidazo (4,5,1-ij) quinolin-6-ones derivatives and their use as poly (adp-ribosyl) transferase (parp) inhibitors
TWI719464B (zh) 2013-03-15 2021-02-21 美商英塞特控股公司 作為bet蛋白抑制劑之三環雜環
EP3019502B1 (en) 2013-07-08 2017-05-17 Incyte Holdings Corporation Tricyclic heterocycles as bet protein inhibitors
WO2015081189A1 (en) 2013-11-26 2015-06-04 Incyte Corporation Bicyclic heterocycles as bet protein inhibitors
US9399640B2 (en) 2013-11-26 2016-07-26 Incyte Corporation Substituted pyrrolo[2,3-c]pyridines and pyrazolo[3,4-c]pyridines as BET protein inhibitors
WO2015095492A1 (en) 2013-12-19 2015-06-25 Incyte Corporation Tricyclic heterocycles as bet protein inhibitors
DK3674302T3 (da) 2014-04-23 2023-04-03 Incyte Holdings Corp 1h-pyrrolo[2,3-c]pyridin-7(6h)-oner og pyrazolo[3,4-c]pyridin-7(6h)-oner som inhibitorer af bet-proteiner
US9527864B2 (en) 2014-09-15 2016-12-27 Incyte Corporation Tricyclic heterocycles as BET protein inhibitors
WO2017075377A1 (en) 2015-10-29 2017-05-04 Incyte Corporation Amorphous solid form of a bet protein inhibitor
KR102643344B1 (ko) 2016-06-20 2024-03-07 인사이트 코포레이션 Bet 저해제의 결정질 고체 형태
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939138A (en) * 1988-12-29 1990-07-03 Sterling Drug Inc. 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo(1,2,3-DE)-1,4-benzoxazines
FR2674855B1 (fr) * 1991-04-03 1994-01-14 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique.

Also Published As

Publication number Publication date
HUT71120A (en) 1995-11-28
KR950011435A (ko) 1995-05-15
CA2133491A1 (en) 1995-04-05
FI944600A0 (fi) 1994-10-03
NZ264596A (en) 1995-11-27
IL111148A0 (en) 1994-12-29
RU94036003A (ru) 1996-08-10
ZA947710B (en) 1995-08-10
FR2710915B1 (fr) 1995-11-24
AU7432994A (en) 1995-04-13
PL305288A1 (en) 1995-04-18
JPH07179466A (ja) 1995-07-18
US5589476A (en) 1996-12-31
HU9402832D0 (en) 1995-01-30
CZ241994A3 (en) 1995-04-12
CN1109471A (zh) 1995-10-04
FR2710915A1 (fr) 1995-04-14
FI944600A (fi) 1995-04-05
NO943682L (no) 1995-04-05
SK119494A3 (en) 1995-05-10
EP0646583A1 (fr) 1995-04-05

Similar Documents

Publication Publication Date Title
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
DK0869126T3 (da) Dithiolanderivater, deres fremstilling og deres terapeutiske virkning
DK374389D0 (da) Arylbenzenoxazolidinoner, deres fremstilling og anvendelse
DK609489A (da) Imidazolderivater, deres fremstilling og anvendelse
NO922275D0 (no) Aryletere, deres fremstilling og fremgangsmaate for behandling
NO953673D0 (no) [1,2,4ÅTriazolo[4,3-aÅkinoksalinderivater, deres fremstilling og anvendelse
DK388989A (da) Acylcyanoguanidiner, deres fremstilling og anvendelse
NO962477L (no) Benzamidderivater, deres fremstilling og deres terapautiske anvendelse
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
DK435289A (da) Piperazindioner, deres fremstilling og anvendelse
DK60893D0 (da) Piperidinderivater, deres fremstilling og anvendelse
NO954763D0 (no) Piperidinderivater, deres fremstilling og anvendelse
DK0835254T3 (da) Oxazolidinonderivater, deres fremstilling og deres terapeutiske anvendelse
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
DK73091D0 (da) Quinoxalinforbindelser, deres fremstilling og anvendelse
DK225089D0 (da) 2-adamantyl-4-isothiazolin-3-oner, deres fremstilling og anvendelse
NO955242D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og deres terapeutiske anvendelse
DK469389D0 (da) Piperidinyl-imidazol-derivater, deres fremstilling og anvendelse
NO934227D0 (no) Pyrrolderivater, fremgangsm}te for deres fremstilling og terapeutiske anvendelse
NO179073C (no) Imid-terminerte polynitrogenforbindelser, deres fremstilling og anvendelse
NO950560D0 (no) Piperazinderivater, deres fremstilling og terapautiske anvendelse
DK592389D0 (da) Penemderivater, deres fremstilling og anvendelse
NO992436D0 (no) N(imidazolylbutyl)benzensulfonamidderivater, deres fremstilling og terapeutiske anvendelse
NO951812D0 (no) Pyrrolderivater, deres fremstilling og anvendelse
NO995966D0 (no) 5-naftalen-1-yl-1,3-dioksan-derivater, deres fremstilling og terapeutisk anvendelse